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During the replication of rhino- and enteroviruses, the translation initiation factor eIF-4g is specifically cleaved by the
virally encoded 2A proteinase. This cleavage has been proposed to lead to the inability of the host cell to translate its own
capped mRNA and to stimulate internal initiation of protein synthesis from the viral mRNA. However, a direct causal
relationship between these effects and 2A proteinase-mediated cleavage of eIF-4g has remained difficult to prove, mainly
because of the toxicity of the 2A proteinase in mammalian expression systems. As an alternative approach, we placed the
cDNA sequences for the human rhinovirus 2 2A proteinase and two mutants defective in proteolytic activity under the
control of an inducible yeast Gal1-10 promoter and stably integrated them into the yeast genome. Induction of the wild-
type enzyme led to changes in cellular morphology, an inhibition of cell division activity, and finally to cell death. As the
yeast homologues of mammalian eIF-4g, p150 and p130, were shown to be refractory to cleavage by human rhinovirus 2A
proteinase both in vivo and in vitro and the rate of protein synthesis was unaffected, the toxicity of the 2A proteinase toward
budding yeast must be due to its interaction with at least one other cellular protein essential for viability. q 1996 Academic
Press, Inc.
INTRODUCTION gruber et al., 1994) and the Leader proteinase of foot-and-
mouth disease virus (FMDV) (Kirchweger et al., 1994). In
Human rhinoviruses (HRVs), the main causative
both cases, cleavage leads to the inability of the cell to
agents of the common cold (Gwaltney, 1975), constitute
translate mRNAs possessing a 5* cap structure (Lloyd etthe most extensive genus of the Picornaviridae. More
al., 1987). Translation of the viral RNA is not inhibited asthan 100 serotypes have been identified (Hamparian et
it is not capped at the 5* end; instead, translation initiatesal., 1987). The genome of the picornaviruses is a single-
internally (Pelletier and Sonenberg, 1988). Indeed, recentstranded RNA molecule of positive polarity encoding a
evidence has shown that the translation of rhino- andpolyprotein which is co- and posttranslationally pro-
enteroviral RNA is stimulated in the presence of 2A pro-cessed by two viral proteinases, designated 2A and 3C,
teinase (Hambidge and Sarnow, 1992; Liebig et al., 1993;to form the mature viral proteins (Hanecak et al., 1982;
Ziegler et al., 1995).Toyoda et al., 1986; Palmenberg, 1990). The 2A protein-
In general, a strictly coordinated cascade of proteolyticase cleaves itself off the growing polypeptide chain at
cleavage events on the polyprotein is obviously neces-its own N-terminus (Toyoda et al., 1986). All other cleav-
sary for efficient viral replication (Pallansch et al., 1984;ages of the polypeptide except one are accomplished by
Kean et al., 1993), but it is still unclear to what extent thethe 3C proteinase: the remaining cleavage event be-
cleavage of cellular proteins tailors cellular metabolismtween VP4 and VP2 is thought to be autocatalytic (Arnold
to an environment optimal for replication. It is unlikely,et al., 1987; Lee et al., 1993).
however, that a plethora of host cell proteins are cleavedAfter infection by rhino-, entero-, or aphthoviruses, cel-
during picornaviral replication. Poliovirus infection, forlular translation is severely impaired. This effect (known
instance, leads to the specific loss of only 14 proteinsas the host-cell shut-off) is proposed to result from the
as judged by two-dimensional gel electrophoresis (Urza´in-cleavage of the p220 subunit of translation initiation fac-
qui and Carrasco, 1989). At present only one cellulartor 4, eIF-4g (Ehrenfeld, 1984), although evidence has
target has been identified for 2A proteinases; this proteinbeen presented to the contrary (Bonneau and Sonenberg,
is the above-mentioned eIF-4g. For the 3C proteinases,1987; Perez and Carrasco, 1992). The cleavage of eIF-
three targets have been characterized: TFIID (the TATA-4g is achieved through direct action of the 2A proteinase
binding protein; Clark et al., 1993) and TFIIIC, which arein rhino- and enteroviruses (Liebig et al., 1993; Sommer-
cleaved by the poliovirus 3C enzyme (Clark et al., 1991),
and histone H3, cleaved by the 3C proteinase of FMDV1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (43)-1-79515-3114; email: timothy.skern@univie.ac.at. (Tesar and Marquardt, 1990; Falk et al., 1990).
109
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 7925 / 6a17$$$341 05-06-96 07:32:06 vira AP: Virology
110 KLUMP ET AL.
Systematic studies of the activities of the viral protein-
ases in vivo are partially dependent on the stable expres-
sion of an active enzyme in an appropriate cell line. How-
ever, at least for the 2A proteinases, only a few reports
have demonstrated successful expression using tran-
sient systems (Sun and Baltimore, 1989, Davies et al.,
1991). One alternative system for expression studies is
the budding yeast Saccharomyces cerevisiae. It is one
of the best studied eukaryotic cell systems because it
allows the application of a large variety of biochemical
and genetic methods. It has therefore become increas-
ingly popular for addressing various aspects of eukary-
otic cell biology. Expression of the poliovirus protein 2BC
in yeast, for instance, shows an inhibition of the secretory
pathway similar to that seen in 2BC-expressing COS-1
cells (Barco and Carrasco, 1995a; Doedens and Kirke-
gaard, 1995).
The difficulties experienced in expressing rhino- and
enteroviral 2A proteinases in mammalian cells led us to
test whether the yeast system could be used to investi-
gate the interactions between these proteinases and a
FIG. 1. (A) Trp1-based yeast integration plasmid for the expressioneukaryotic cell. Specifically, we wished to ask whether
of HRV2 2A proteinase and mutants thereof. Expression from the Gal10the expression of a 2A proteinase is toxic for yeast cells
portion of the bidirectional Gal1-10 promoter leads to the synthesis of
and whether such a toxicity was determined by cleavage a fusion protein consisting of 16 plasmid-derived amino acids (Vector),
of the recently described homologues of eIF-4g in yeast, 28 amino acids of the C-terminus of VP1, and all 142 amino acids of
HRV2 2A proteinase. Restriction sites used for manipulation are shownnamely the products of the TIF4631 and TIF4632 genes,
(as described under Material and Methods); a circle indicates the losscalled p150 and p130 (Lanker et al., 1992; Goyer et al.,
of a site during construction. (B) Schematic drawing of the mature1993). The experiments described in this paper were
HRV2 2A proteinase. The active site cysteine residue 106 of the mature
designed to address these questions. enzyme is indicated. Amino acids surrounding the active site of the
different 2A proteins (2A, 2A-Ser, and 2A-D3Gly) are shown. The proteo-
lytic activity of the different 2A proteins relative to the wild-type enzymeMATERIAL AND METHODS
is indicated. Data are taken from Liebig et al. (1991) and Kirchweger
et al. (1994).Chemicals
Restriction endonucleases and DNA-modifying en-
mM Tris–HCl, pH 8.0, 50 mM NaCl, 1 mM EDTA, 5 mMzymes were from New England Biolabs (Beverly, MA)
DTT, and 5% glycerol (Liebig et al., 1993).and reactions were performed as recommended by the
supplier. Glucose was purchased from Merck, galactose
Vector constructions and genetic manipulationsand adenine sulfate from Sigma.
Standard techniques were used for DNA manipula-Strains, media, and reagents
tions (Maniatis et al., 1982) and yeast integrative transfor-
mations (Rose et al., 1990). The expression vector usedAll strains were derivatives of S.cerevisiae K699
(W303a) (MATa, ade2-1, trp1-1, can1-100, leu2-3,112, in this study (Fig. 1A) is a derivative of the TRP1-based
yeast integration vector YIplac204 (Gietz and Sugino,his3-11,15, ura3, GAL, [psi/]) or 1107 (MATa, HMLa,
HMRa, HO-bGal, ura3, his4/, ade2-1, can1-100, his3, 1988) into which a fusion of the S.cerevisiae Gal1-10
promoter and the CLB2 gene (encoding a B-type cyclin)leu2-3, 112, trp1-1) (kind gifts from Kim Nasmyth). The
cells were grown in YEP medium (1% yeast extract, 2% has been inserted (Surana et al., 1993). The CLB2 frag-
ment was first removed by restriction with EcoRI, thebactopeptone, 55 mg/liter adenine sulfate) supplemented
as indicated with 2% glucose (YPD) or galactose (YPGal). protruding ends were made flush with the Klenow frag-
ment of Escherichia coli DNA polymerase I, and the 5300-For radioactive labeling, 0.8% yeast nitrogen broth (YNB;
Difco) containing all essential amino acids except methi- bp fragment was isolated from an agarose gel. This vec-
tor was then ligated to a 710-bp NcoI/EcoRV Klenow-onine was used. AP-conjugated goat anti-rabbit second-
ary antibody was purchased from Stratagene and pro- filled-in fragment from pET8c/HRV2 2A (Liebig et al.,
1993) in such a way that transcription is driven by theteins were detected chromogenically with nitro-blue
tetrazolium chloride and 5-bromo-4-chloro-3-indolylphos- Gal10 portion of the Gal1-10 promoter. This vector is
referred to as YIp2A (Fig. 1A). On induction with galac-phate according to Ausubel et al. (1989). Buffer A is 50
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tose, the expressed protein consists of 16 plasmid-de- per OD600 unit was added; labeling was for 30 min at 307.
Cells were collected by centrifugation, resuspended inrived amino acids, the C-terminal 28 amino acids of VP1,
and all 142 amino acids of HRV2 2A proteinase. The buffer B, washed, and disrupted. Incorporation was de-
termined after TCA precipitation of a 5-ml aliquot byexpression vector YIp2A-Ser carries the mutations G:C
and T:A at nucleotides 3477 and 3478 of the HRV2 cDNA counting of the insoluble material in a Packard scintilla-
tion counter.(numbering according to Skern et al., 1985), respectively,
which lead to the amino acid change C106S at the active
Determination of cell viabilitysite (Fig. 1B). The deletion of nucleotides 3471–3476 and
3480–3482 from the wild-type cDNA eliminates the three Constant volumes of cultures growing in YPGal were
glycine residues surrounding the active site cysteine to diluted at different times postinduction and plated on
give the expression vector YIp2A-D3Gly. Linearization YPD plates. The percentage of viable cells (cells produc-
with BstXI was used to direct integration of these vectors ing colonies) was estimated by counting colony numbers
into the yeast chromosomal trp-locus. and relating them to the total cell number originally deter-
mined.
Proteinase expression and immunoblot analysis
Proteinase cleavage assay of p150/p130
For expression of the different proteinase mutants,
Cleavage assays on yeast extracts were performed inyeasts bearing the integrated expression vectors were
cleavage buffer (50 mM NaCl, 50 mM Tris–HCl, pH 8.0,grown for 16 hr in YPD at 307 to reach the exponential
5 mM DTT) in a final volume of 20 ml at 307 for 30 min.growth phase, washed once in YEP, and resuspended
Thirty micrograms of yeast (K699) crude cell extract wasin YPGal for induction of protein expression or in YPD
incubated with 2 mg of purified HRV2 2A proteinase (Lie-as an uninduced control. Following determination of the
big et al., 1993), purified 2A proteinase of coxsackievirusoptical density of the cultures at 600 nm and determina-
B4 (CVB4 2A) (Liebig et al., 1993), or the Lb form of thetion of cell viability (see below), crude cell extracts were
Leader proteinase from FMDV (Kirchweger et al., 1994).prepared. Cells were collected by centrifugation at 47 at
Proteins were separated via 6% SDS–PAGE, electroblot-the indicated time points, washed once with ice-cold
ted, and probed with the rat antiserum to the p150/p130wash buffer (buffer W: 50 mM NaCl, 50 mM Tris–HCl,
proteins as described above.pH 8.0, 1 mM EDTA), and resuspended in breakage
The cleavage of eIF-4g in HeLa cell cytoplasmic ex-buffer (buffer B: buffer W plus 50 mM DTT, 2 mg/ml pep-
tracts by 2A proteinases from HRV2 and CVB4 and thestatin, 1 mg/ml leupeptin, and 1 mM PMSF). An equal
analysis of the state of eIF-4g by immunoblotting usingvolume of glass beads was added to the suspension and
the rabbit anti-eIF-4g peptide 7 antiserum were done ascells were broken by two bursts of vigorous vortexing
described (Kirchweger et al., 1994).for 4 min at 47. An aliquot was withdrawn for protein
concentration determination using the BCA reagent
RESULTS(Pierce, Rockford, IL) (Lowry et al., 1951).
For immunoblot analysis, protein sample buffer was Expression of the HRV2 2A proteinase
added and the mixture was immediately boiled at 957 for
5 min. The glass beads and cell debris were removed The presumed toxicity of the 2A proteinase of HRV2
found in many eukaryotic cell lines led us to develop aby centrifugation and 30 mg of each cell extract was
loaded onto a 15% (v/v) SDS–polyacrylamide gel. Pro- system in which the expression vectors were chromo-
somally integrated into the trp-locus of the yeast genometeins were transferred to Immobilon-P membranes (Milli-
pore) by electroblotting. The blots were then blocked in (Fig. 1A). This strategy was designed to exclude any pos-
sible counterselection and to maintain constant copy11 PBS containing 3% BSA for 2 hr at room temperature
and afterward incubated for 4 hr with fresh blocking numbers of the 2A genes throughout expression. Stable
integration was confirmed by monitoring the presence ofbuffer containing a 1:200 dilution of an affinity-purified
polyclonal rabbit anti-HRV2 2A antiserum or with a poly- the 2A proteinase cDNA sequences using PCR amplifica-
tion and direct DNA sequencing of the products (dataclonal rat anti-yeast eIF-4F antiserum (Lanker et al., 1992,
a kind gift of M. Altmann) diluted 1:500 in TBS containing not shown). The integrated sequences were stable for
long periods under noninducing conditions.0.5% BSA. Bound antibodies were detected by using alka-
line phosphatase-conjugated goat anti-rabbit antibody. To examine whether the wild-type 2A proteinase
could be expressed in yeast, cells were grown andFor radioactive labeling, cells were grown overnight in
0.8% YNB containing unlabeled methionine and 1% glu- protein expression was induced with galactose as de-
scribed under Material and Methods. After preparationcose. Cells were washed and protein expression was
induced in prewarmed YNB containing 1% galactose. of crude extracts, the proteins were separated by
PAGE and probed with the affinity-purified anti-2A pro-Samples were removed at the time points indicated and
50 mCi [S35]methionine (specific activity 1175 Ci/mmol) teinase antiserum. The result is shown in Fig. 2. In
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FIG. 2. Kinetics of expression of the 2A proteinase and two mutants (2A-Ser and 2A-D3Gly) driven by the Gal1-10 promoter. Samples of the yeast
cultures were taken at 0, 4, 6, and 8 hr after induction of expression in YPGal, and crude extracts were prepared as described under Material and
Methods. 30 mg of each extract was separated on 15% polyacrylamide gels, blotted onto PVDF membranes, and probed with affinity-purified
polyclonal rabbit anti-HRV2 2A proteinase antiserum. The positions of the mature 2A proteinase (16 kDa) and the uncleaved DVP1-2A fusion protein
(20 kDa) are indicated. Key: M, molecular weight markers of MWs 190, 125, 88, 65, 56, 38, and 33 kDa; r2A, 50 ng of purified recombinant HRV2
2A proteinase.
extracts expressing the wild-type 2A proteinase, an ever, cells expressing wild-type 2A proteinase were un-
able to form colonies. In contrast, none of the active siteimmunoreactive species which comigrated with puri-
fied recombinant HRV2 2A proteinase was detectable mutants (2A-Ser, 2A-D3Gly) showed any negative effect
on growth. This clearly demonstrates that expression of4 hr after induction and increased in intensity with
time (Fig. 2, lanes 2A). Thus, the wild-type enzyme was the proteolytically active enzyme is lethal for yeast.
capable of cleaving itself off the DVP1-2A fusion pro-
tein to produce the mature enzyme in the yeast cells. Kinetics of 2A toxicity in yeast and overall cell
This experiment was then repeated with yeasts con- morphology
taining 2A proteinase cDNA sequences which had
To determine the kinetics of toxicity for yeast cells afterbeen specifically mutated at the active site (Fig. 1B).
induction of proteinase expression, a constant volume ofThe mutation C106S reduces the proteolytic activity
cells was removed at indicated times postinduction (Fig.by at least 500-fold compared to that of the wild-type
3C), diluted, and plated on YPD plates. Colonies (formedenzyme (Kirchweger et al., 1994), whereas the removal
by single viable cells) were counted and viability wasof the three glycine residues completely inactivates
estimated by correlating these numbers with the totalthe enzyme (Liebig et al., 1991). On induction of protein
cell count determined photometrically at 600 nm at theexpression from yeasts bearing cDNA sequences of
given time points. The results are shown in Fig. 3C. Via-the HRV2 2A-Ser or 2A-D3Gly proteinases, immunolog-
bility of 2A proteinase-expressing yeast cells began toically detectable proteins were also visible after 4 hr of
decline after 2 hr to less than 5% after 10 hr of induction,induction (Fig. 2). However, in both cases, the proteins
whereas expression of the active-site mutants (2A-Ser,migrated more slowly with an estimated molecular
2A-D3Gly) did not affect viability.weight of about 20 kDa. This corresponds to the un-
Figure 4 shows the overall morphology of the express-cleaved DVP1-containing fusion protein of 186 amino
ing cells as seen under light microscopy using Nomarskyacids for 2A-Ser (theoretical Mr 20.5 kDa) and 183
differential interference contrast optics. Cells expressingamino acids for 2A-D3Gly (theoretical Mr 20.3 kDa).
wild-type proteinase enlarge up to about twice the sizeQuantification of the immunoblot shown in Fig. 2 re-
of wild-type cells. The central vacuole was not visible;vealed that about 10 ng of both the active and the inactive
instead, the entire cell seemed to be filled with smallforms of the recombinant proteins was present in 30 mg
vesicles, a phenotype reminiscent of certain mutants ofof the total yeast extract. Thus, the recombinant proteins
vacuolar morphogenesis (Wada et al., 1992). This pheno-represent about 0.033% of total cellular protein.
type was seen neither in uninduced cells nor in cells
expressing any of the active-site mutants.Effect of proteinase expression on growth of budding
yeast
Effect of proteinase activity on protein synthesis
To determine whether expression of 2A proteinase had
an adverse effect on yeast growth, cells were streaked In mammalian cells, the 2A proteinase of rhino- and
enteroviruses is known to lead to a reduction of transla-out on noninducing (YPD) and inducing (YPGal) plates.
Figures 3A and 3B show the results after 3 days of incu- tion of capped mRNA (Davies et al., 1991). To examine
whether a reduction in the rate of protein synthesis wasbation at 307; under noninducing conditions, no differ-
ences in growth were seen. On galactose plates, how- responsible for the loss of viability, proteinase expres-
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FIG. 3. Growth and survival of 2A-expressing yeasts on noninducing (YPD) and inducing (YPGal) media. To measure growth, parent yeast strain
K699 and derivatives 2A, 2A-Ser, and 2A-D3Gly containing the chromosomally integrated expression vectors were plated on (A) YPD and (B) YPGal
plates and grown for 2 days at 307. (C) For survival rates, the replating efficiency of yeasts expressing 2A proteinase was measured. At the indicated
time points after induction of proteinase expression, fixed volumes of yeast cultures were diluted and plated on YPD plates to estimate the percentage
of viable cells relative to the total cell count determined photometrically at 600 nm.
sion was induced with galactose. At the time points indi- 2 and 6 hr after induction. During this period, the rate
of protein synthesis in cells expressing the mature 2Acated in Fig. 5, the OD600 was measured and the cells
proteinase closely paralleled that in the wild-type 699were washed, resuspended in medium containing [S35]-
strain and in the strains expressing the inactive protein-methionine, and incubated for a further 30 min. Cells
ase mutants.were collected by centrifugation and disrupted, and TCA-
precipitable material was measured. The incorporation
Effect of proteinase activity on p150/p130 in vitro andof [S35]methionine into protein was expressed relative to
in vivothe total number of cells in the culture, as determined by
the OD600 . Figure 5 shows that 2A proteinase expression The lack of influence of the expression of the 2A pro-
does not alter the rate of incorporation of [S35]methionine teinase on protein synthesis in yeast cells implied that
during the time course of the induction. Figure 3C shows the yeast homologues p150 and p130 (Lanker et al., 1992)
of the 220-kDa subunit of eukaryotic translation initiationthat the greatest loss in cell viability occurred between
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FIG. 4. Morphology of yeast cells (strain 1107 ) (A) immediately after induction and (B) after 8 hr of expression of 2A proteinase and derived
mutants. Aliquots of cultures were taken at the indicated time points and observed under the light microscope using Nomarsky optics. Note the
abnormal cell morphology 8 hr after induction of the wild-type proteinase.
factor 4 (eIF-4g) were not substrates for this enzyme. In This experiment suggested that the yeast homologues
were not cleaved by the HRV2 2A proteinases. To investi-order to examine the state of these eIF-4 subunits in vivo,
samples of the yeast culture expressing the wild-type gate whether insufficient enzyme is present in the yeast
cell or whether the lack of cleavage was due to compart-HRV2 2A proteinase were taken at the indicated time
points after induction and crude extracts were prepared mentalization of the proteinase resulting in separation
from the eIF-4g homologues, the ability of the HRV2 2Aand analyzed for cleavage of p150 or p130 by immu-
noblotting (Fig. 6). Expression of the 2A proteinase did proteinase as well as that of CVB4 (Liebig et al., 1993)
and of the Leader proteinase of FMDV (Kirchweger etnot lead to any detectable cleavage, even after 8 hr, a
time point at which 90% of the cells were no longer viable. al., 1994) to cleave these proteins was tested in vitro. The
ability of these purified recombinant enzymes to cleaveIt is noticeable, however, that the cross-reacting material
migrating at about 55 kDa is reduced in intensity during endogenous eIF-4g in HeLa extracts in the standard
assay of Kirchweger et al. (1994) is shown in Fig. 7A. Forthe incubation. The identity of this protein is unknown;
however, as its intensity is reduced to the same extent both HRV2 and CVB4 2A proteinases, a concentration of
1 mg/ml is sufficient to cleave 50% of the eIF-4g contentin the parent K699 strain, the reduction is not related to
the expression of the HRV2 2A proteinase. of 10 mg of HeLa cell cytoplasmic extract under the condi-
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FIG. 5. Expression of HRV2 2A proteinase in yeast does not interfere with protein synthesis. Cells were grown as described under Material and
Methods. At the indicated times after induction, samples of the cultures were labeled with [S35]methionine for 30 min. Incorporation, as measured
after TCA precipitation of proteins, is given per 106 cells. Data shown are the average of three independent experiments.
tions employed (Fig. 7A, lanes c, HRV2 and CVB4). No proteolytically cleavable conformation. Thus, 2A protein-
ase expression in yeast does not mirror the cleavage ofcleavage is observed with the C106S active site mutant
(Fig. 7A, lane c, HRV2 Ser-2A). the eIF-4g homologue seen in virus-infected HeLa cells.
Two micrograms of each of the purified proteinases
(final concentration 100 mg/ml) was then incubated with DISCUSSION
30 mg of crude yeast cell extract under the same condi-
tions (Fig. 7B). Under these conditions, neither the 2A In this report, we have shown the inducible expression
of a proteolytically active 2A proteinase of HRV2 andproteinase of HRV2 nor that of CVB4 cleaved the yeast
homologues in the crude extract in vitro, although 30 two inactive mutants with either greatly reduced or no
proteolytic activity from chromosomally integrated copiestimes more enzyme was present than required to cleave
50% of the eIF-4g in the same amount of HeLa extract. in yeast. The stable integration of the 2A expression vec-
tors into the yeast genome has many advantages overIn contrast, the Lb proteinase converted the 130-kDa sub-
unit of yeast eIF-4 to a faster migrating product (Fig. the usage of high-copy expression vectors. First, yeasts
can be grown under nonselective conditions for longer7B), showing that at least the 130-kDa subunit was in a
FIG. 6. Expression of 2A proteinase in vivo does not lead to cleavage of the yeast eIF-4g homologues p150 and p130. At the indicated time
points (hours), samples of the indicated cultures were withdrawn, crude extracts were prepared, and 30 mg per lane was separated via 6% SDS–
PAGE. After blotting, proteins were subjected to Western analysis using polyclonal rat anti-yeast eIF-4 antiserum (Lanker et al., 1992). Positions of
selected molecular weight markers are shown on the left, those of p150 and p130 on the right. The 70-kDa protein detected by the antiserum is
the cross-reacting yeast protein SSA1 (Slater and Craig, 1989). Key: M, molecular weight standards.
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with yeast growth. This effect was seen with both yeast
strains used in this study (data not shown), showing that
toxicity is not yeast strain specific. Furthermore, this viral
proteinase is only toxic for budding yeast when proteo-
lytic activity is present. Recent work has also shown that
expression of the 2A proteinase of another picornavirus,
poliovirus type 1, from a high-copy plasmid was toxic for
yeast; however, neither the requirement for proteolytic
activity nor the basis of the toxicity was examined (Barco
and Carrasco, 1995b).
The uniform increase in induction of the amounts of
all 2A forms mentioned above implied that there was no
difference in the rate of protein synthesis in these cells.
Further support for this idea was given by the measure-
ment of total protein synthesis (Fig. 4); no significant
difference was observed between cells expressing the
wild-type enzyme and those expressing the inactive mu-
tants. Therefore, cells which have lost viability as mea-
sured by the ability to grow on solid medium appear to
translate normally.
This inability of the 2A proteinase to interfere with
protein synthesis led us to examine the fate of the yeast
proteins which are homologous to the eukaryotic transla-
tion initiation factor eIF-4g. This is the only protein in
infected cells whose 2A cleavage site has been charac-
terized to date. The two yeast homologues are the prod-
ucts of the genes TIF4631 and TIF4632, referred to as
p150 and p130, respectively. Figures 6 and 7B show that
FIG. 7. Yeast p150 and p130 are not cleaved by purified recombinant neither of these yeast eIF-4g homologues are recognized
2A proteinases of HRV2 and CVB4 in vitro. (A) HeLa cytoplasmic cell as substrates by the HRV2 2A proteinase either during in
extract (10 mg) was incubated for 30 min at 307 with either buffer A
vivo expression or when purified recombinant proteinase(lane N) or the indicated proteinases at the following final concentra-
was incubated with yeast extract. That at least the p130tions: lane a, 100 mg/ml; lane b, 10 mg/ml; lane c, 1 mg/ml; lane d, 0.1
protein was available for proteolysis in vitro was evi-mg/ml. Reactions were stopped by the addition of Laemmli sample
buffer, and proteins were separated by SDS–PAGE on a gel containing denced by the observed cleavage by the purified recom-
6% acrylamide. The gel was blotted onto nitrocellulose and probed binant Leader proteinase of FMDV.
with rabbit anti-eIF-4g peptide 7 antiserum. cpa , N-terminal cleavage Thus, the above results show that the toxicity of theproducts. (B) 30 mg of crude yeast cell extract from K699 was incubated
active enzyme must be the consequence of the cleavagefor 30 min at 307 with 2 mg (final concentration 100 mg/ml) of the
of or interaction with some other essential yeast genefollowing purified recombinant 2A proteinases: lane 1, buffer alone (B);
lane 2, Leader proteinase of FMDV; lane 3, CVB4 2A proteinase; lane product(s) which does not affect protein synthesis. In an
4, HRV2 2A-Ser proteinase; lane 5, HRV2 2A proteinase. The samples attempt to identify possible candidates, we searched the
were analyzed by immunoblotting as described for Fig. 6. Positions of
Swissprot protein sequence database with the recogni-selected molecular weight markers are shown on the right, those of
tion sequence of the HRV2 2A proteinase defined asp150 and p130 on the left.
RXX(I/L)X(T/S)XG(P/F) by Sommergruber et al. (1994). As
would be expected from the cleavage data, this consen-
sus sequence was not found in either the p150 or theperiods without loss of the integrated gene (Zhu et al.,
1986). In addition, during expression, the number of 2A p130 protein. In addition, none of the known initiation
and/or translation factors was found to contain this se-sequences does not seem to vary, whereas high-copy
plasmids may be lost as a consequence of the produc- quence. However, two proteins were found in the search,
the atp13 protein precursor (Swissprot Accession No.tion of a toxic enzyme. Therefore, the expression kinetics
of the wild-type 2A proteinase and the two mutant pro- P23115) and the ubiquitin–protein ligase E3 component
(P19812). The mitochondrial location of the atp13 proteinteinases were highly comparable as can be clearly seen
by the uniform increase in the amounts of all 2A forms argues against its involvement in 2A proteinase-medi-
ated toxicity. However, further experiments will be neces-after induction of expression (Fig. 2).
As is demonstrated in Fig. 3, expression of the wild- sary to show whether either of these proteins can serve
as substrates of 2A proteinases and whether their cleav-type HRV2 2A proteinase was lethal for budding yeast,
whereas the expression of the mutants did not interfere age contributes to toxicity.
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to an inactive form: A mechanism for inhibition of host cell polymer-In mammalian systems, activity of 2A proteinases not
ase III transcription by poliovirus. EMBO J. 10, 2941–2947.only abolishes cap-dependent translation, but also en-
Clark, M. E., Liebermann, P. M., Berk, A. J., and Dasgupta, A. (1993).hances translation initiation from picornaviral IRESs as Direct cleavage of human TATA-binding protein by poliovirus Prote-
has been shown in vitro with both HRV2 and poliovirus ase 3C in vivo and in vitro. Mol. Cell. Biol. 13, 1232–1237.
2A proteinases (Hambidge and Sarnow, 1992; Liebig et Davies, M. V., Pelletier, J., Meerovich, K., Sonenberg, N., and Kaufman,
R. J. (1991). The effect of poliovirus proteinase 2Apro expression onal., 1993; Ziegler et al., 1995). The mechanism of this
cellular metabolism. J. Biol. Chem. 266, 14714–14720.stimulation has not yet been elucidated, although it has
Doedens, J. R., and Kirkegaard, K. (1995). Inhibition of cellular proteinbeen suggested to occur via the C-terminal cleavage
secretion by poliovirus proteins 2B and 3A. EMBO J. 14, 894–907.
product of p220 (Lamphear et al., 1995). In contrast, re- Ehrenfeld, E. (1984). Picornavirus inhibition of host cell protein synthe-
cent data have been presented indicating that the stimu- sis. Comp. Virol. 19, 177–221.
lation of IRES-driven translation is not dependent on p220 Falk, M. M., Grigera, P. R., Bergmann, I. E., Zibert, A., Multhaup, G., and
Beck, E. (1990). Foot-and-mouth disease virus proteinase 3C inducescleavage (Ventoso and Carrasco, 1995). Internal initiation
specific proteolytic cleavage of host cell histone H3. J.Virol. 64, 748–of translation (Jang et al., 1988) was also shown to exist
756.in yeast cells by using an enteroviral IRES (Iizuka et al.,
Frolova, L., Le-Goff, X., Rasmussen, H. H., Cheperegin, S., Drugeon, G.,
1994). As many translation initiation factors are highly Kress, M., Arman, I., Haenni, A. L., Celis, J. E., and Philippe, M. (1994).
conserved between mammalian and yeast cells (Na- A highly conserved eukaryotic protein family possessing properties
of polypeptide chain release factor. Nature 372, 701–703.randa et al., 1994; Altmann et al., 1989; Schwelberger et
Gietz, R. D., and Sugino, A. (1988). New yeast– E. coli shuttle vectorsal., 1993; Frolova et al., 1994), it will be of interest to
constructed with in vitro mutagenised yeast genes lacking six-baseexamine whether IRES-driven initiation of translation is
pair restriction sites. Gene 74, 527–535.
stimulated in yeasts during the initial period of 2A pro- Goyer, C., Altmann, M., Lee, H. S., Blanc, A., Deshmuckh, M., Woolford,
teinase expression. J. Jr., Trachsel, H., and Sonenberg, N. (1993). TIF4631 and TIF4632:
Two yeast genes encoding the high-molecular-weight subunits ofWith the usage of inducible yeast expression systems
the cap-binding protein complex (eukaryotic initiation factor 4F) con-(this report; Barco and Carrasco, 1995b), isolation and
tain an RNA recognition motif-like sequence and carry out an essen-definition of the crucial protein substrate(s) of picornavi-
tial function. Mol. Cell. Biol. 13, 4860–4874.
ral 2A proteinases should be facilitated. This will help Gwaltney, J. M., Jr. (1975). Medical reviews—Rhinoviruses. Yale J. Biol.
us to understand more clearly the role of these enzymes Med. 48, 17–45.
in virus-infected mammalian cells. Hambidge, S. J., and Sarnow, P. (1992). Translational enhancement
of the poliovirus 5* noncoding region mediated by virus-encoded
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